000 | 01227 a2200337 4500 | ||
---|---|---|---|
005 | 20250517182940.0 | ||
264 | 0 | _c20180910 | |
008 | 201809s 0 0 eng d | ||
022 | _a1875-5453 | ||
024 | 7 |
_a10.2174/1389200218666171031121905 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aNagel, Simone | |
245 | 0 | 0 |
_aIsoniazid Resistance and Dosage as Treatment for Patients with Tuberculosis. _h[electronic resource] |
260 |
_bCurrent drug metabolism _c2017 |
||
300 |
_a1030-1039 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntitubercular Agents _xadministration & dosage |
650 | 0 | 4 | _aDrug Resistance, Bacterial |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIsoniazid _xadministration & dosage |
650 | 0 | 4 |
_aMycobacterium tuberculosis _xdrug effects |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aTuberculosis, Pulmonary _xdrug therapy |
700 | 1 | _aStreicher, Elizabeth M | |
700 | 1 | _aKlopper, Marisa | |
700 | 1 | _aWarren, Robin M | |
700 | 1 | _aVan Helden, Paul D | |
773 | 0 |
_tCurrent drug metabolism _gvol. 18 _gno. 11 _gp. 1030-1039 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2174/1389200218666171031121905 _zAvailable from publisher's website |
999 |
_c27738040 _d27738040 |